Culture Connect Featured Event
Ticket Price: free
For Tickets, Contact: N/A
Do you have a child with Pervasive Developmental Disorder and hyperactivity?
Yale Child Study Center is conducting a research study to test the effectiveness of a non-stimulant medication, extended-release guanfacine (Intuniv®), for children with PDD and hyperactivity.
Eligible children are at least 5 but younger than 14 years old, with autism, Asperger’s, or PDD-NOS, and clinically significant hyperactivity, currently medication-free or on ineffective medication.
CONTACT: 203-737-5317 or visit: http://childstudycenter.yale.edu/autism/research/guan-pdd.aspx